source
- Promising pancreatic cancer drug daraxonrasib shows near-double survival, patients await expanded accessAmy Johnston, diagnosed with pancreatic cancer last year, has undergone chemotherapy and surgery and is now in a clinical trial that hopes to delay disease progression. She expects results by the e…
- Eli Lilly cuts German weight-loss syringe investment by half amid new cost-cutting lawEli Lilly said it will cut its planned investment in Germany for the production of weight‑loss syringes. The company had originally earmarked $2.67 billion, but will now invest roughly half that a…